QQ客服 官方微博 反馈留言

	TLR9 agonist enhances radiofrequency ablation-induced CTL responses, leading to the potent inhibition of primary tumor growth and lung metastasis
	Xu Aizhang[1]; Zhang Lifeng[2]; Yuan Jingying[3]; Babikr Fatma[4]; Freywald Andrew[5]; Chibbar Rajni[6]; Moser Michael[7]; Zhang Wenjun[8]; Zhang Bing[9]; Fu Zhaoying[10]
刊名	Cellular & molecular immunology
	2018
关键词	CTL response RFA TLR9 agonist antitumor immunity metastasis
ISSN号	2042-0226
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/2170269
专题	上海大学
作者单位	1.[1]Cancer Research, Saskatchewan Cancer Agency, University of Saskatchewan, Saskatoon, SK, Canada. 2.[2]Department of General Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China. 3.[3]Cancer Research, Saskatchewan Cancer Agency, University of Saskatchewan, Saskatoon, SK, Canada. 4.[4]Cancer Research, Saskatchewan Cancer Agency, University of Saskatchewan, Saskatoon, SK, Canada. 5.[5]Department of Pathology, University of Saskatchewan, Saskatoon, SK, Canada. 6.[6]Department of Pathology, University of Saskatchewan, Saskatoon, SK, Canada. 7.[7]Department of Surgery, University of Saskatchewan, Saskatoon, SK, Canada. 8.[8]Department of Bioengineering, University of Saskatchewan, Saskatoon, SK, Canada. 9.[9]Biomedical Science and Technology Research Center, School of Mechatronic Engineering and Automation, Shanghai University, Shanghai, China. 10.[10]Department of Immunology, College of Medicine, Yian-An University, Yian-An, China.
推荐引用方式 GB/T 7714	Xu Aizhang[1],Zhang Lifeng[2],Yuan Jingying[3],et al. TLR9 agonist enhances radiofrequency ablation-induced CTL responses, leading to the potent inhibition of primary tumor growth and lung metastasis[J]. Cellular & molecular immunology,2018.
APA	Xu Aizhang[1].,Zhang Lifeng[2].,Yuan Jingying[3].,Babikr Fatma[4].,Freywald Andrew[5].,...&Xiang Jim[11].(2018).TLR9 agonist enhances radiofrequency ablation-induced CTL responses, leading to the potent inhibition of primary tumor growth and lung metastasis.Cellular & molecular immunology.
MLA	Xu Aizhang[1],et al."TLR9 agonist enhances radiofrequency ablation-induced CTL responses, leading to the potent inhibition of primary tumor growth and lung metastasis".Cellular & molecular immunology (2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。